Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CUE-102 |
Trade Name | |
Synonyms | CUE 102|CUE102 |
Drug Descriptions |
CUE-102 is a fusion protein comprised of HLA molecules presenting WT1-derived peptide epitopes and affinity-attenuated IL-2, which potentially increases antitumor immune response against WT1-expressing tumors (Cancer Res (2020) 80 (16_Supplement): 6699). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C187689 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CUE-102 | CUE-102 | 0 | 1 |